Senior insider sale
TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$141.2K
3.25K shares
What this filing means
COUGHLIN TIMOTHY plans to sell 3.25K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $141.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/15/2026ACC: 0001376043-26-000004
Director
Since May 2019
3.25K
Shares to sell
$141.2K
Approx. market value
3.25K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Awards
N/A
5/15/2026
3.25KTotal acquired3.25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/15/2026 | Restricted Stock Awards N/A | 3.25K | — |
| Total | 3.25K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
3.25K
Market value
$141.2K
5/15/2026
Total
Units
3.25K
Value
$141.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/15/2026 | 3.25K | $141.2K | Nasdaq | Planned |
| Total | 3.25K | $141.2K | ||